Target Group Inc. (CBDY)
OTCMKTS · Delayed Price · Currency is USD
0.0015
-0.0005 (-23.68%)
Oct 21, 2025, 9:43 AM EDT
Target Group Market Cap
Target Group has a market cap or net worth of $1.17 million as of October 21, 2025. Its market cap has decreased by -36.67% in one year.
Market Cap
1.17M
Enterprise Value
3.59M
Revenue
5.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 28, 2015, Target Group's market cap has decreased from 8.63M to 1.17M, a decrease of -86.41%. That is a compound annual growth rate of -18.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 1.17M | 35.71% |
| Dec 31, 2024 | 863.84K | -23.91% |
| Dec 29, 2023 | 1.14M | -54.00% |
| Dec 30, 2022 | 2.47M | -54.55% |
| Dec 31, 2021 | 5.43M | -32.35% |
| Dec 31, 2020 | 8.03M | -28.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.18M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |